Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement . Securities Purchase Agreement On January 29, 2026, ProMIS Neurosciences Inc. (the “ Company ”) entered into a S
Unregistered Sale of Equity Securities. The information contained in Item 1.01 relating to the Offering is hereby incorporated by reference into this Item 3.0
Other Information. On January 30, 2026, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached her
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Common Share Warrant 4.2 Form of Pre-Funded Warrant 10.1 Form of Se